Clinical Trials
21 trialsNCT03418038 2026-04-16
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Mayo Clinic
Phase 2 Recruiting
NCT03546686 2026-03-27
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer
University of Texas Southwestern Medical Center
Phase 2 Active not recruiting
NCT05229341 2026-02-23
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
City of Hope Medical Center
Phase NA Recruiting
NCT04150939 2026-02-17
Cryoablation for the Treatment of Metastatic Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04009044 2025-10-09
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
Northwestern University
Phase 2 Active not recruiting
NCT04790045 2023-10-03
LymBIO
IRCCS San Raffaele
Phase 4 Not yet recruiting
NCT00665457 2023-09-13
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
University of Nebraska
Phase 2 Terminated
NCT04880681 2023-05-01
Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle
Region Skane
Phase NA Unknown
NCT02019303 2022-11-01
Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer
University of Utah
Phase NA Completed
NCT04759053 2021-02-17
Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules
Kafrelsheikh University
Phase NA Completed
NCT00700778 2021-01-25
Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
Fox Chase Cancer Center
Phase NA Terminated
NCT03273426 2020-04-09
Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.
Seoul National University Hospital
Phase NA Completed
NCT01259089 2019-09-11
Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Northwestern University
Phase 1/2 Completed
NCT03946943 2019-07-10
Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma
The First Hospital of Jilin University
Phase 2 Unknown
NCT02594943 2018-11-26
Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
Region Skane
Phase NA Withdrawn
NCT00804245 2018-07-03
C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer
Wake Forest University Health Sciences
Phase 1 Completed
NCT00194779 2018-03-12
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
University of Washington
Phase 2 Completed
NCT00466752 2017-11-22
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
University of Washington
Phase 2 Completed
NCT00715793 2017-10-03
UPCI-07-008
University of Pittsburgh
Phase 1/2 Completed
NCT00903214 2013-04-29
Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Withdrawn
NCT00673569 2010-08-09
Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed